Accessing Capital and Reaching Liquidity: The Dramatic Catalyst of the JOBS Act
Thursday, June 27th: 8:20AM- 9:10AM
The JOBS Act has created many new channels for companies exploring entrance into the public markets. Of particular interest are changes to Regulation D, Regulation A, which could become a major new financing tool for smaller companies to enter the public markets via a more friendly on-ramp.
Experts maintain that sustained growth in the industry is directly tied to a healthy and ever-expanding number of life sciences companies entering public markets. However, a funding gap for companies in mid-level rounds has threatened to stymie industry growth, and this gap may be expanding, in which earlier-stage companies may be mired in purgatory.
The JOBS Act — with the expansion of the investor pool for private companies, new accreditation levels, and more efficient compliance guidelines — may infuse more later-round capital and in turn facilitate more entrance to public markets. This expert panel will discuss the logistics and opportunity of the JOBS Act, exploring:
- How has the JOBS Act changed the traditional definition of Reg A and Reg D?
- Which companies are best-suited to undertake non-traditional late-round financing methods?
- How can companies maintain liquidity, float, sharevalue, and avoid toxic death spirals?
- What must companies do before the fundraising stage to secure valuation?
- What prior case studies exist for new fundraising strategies?
- How do potentially new strategies appeal to early institutional investors?
- What is the investor demographic that participates in Reg A & Reg D?
- What is the long-term strategy/exit strategy of companies engaging in a new IPO on-ramp?
- How does the expanding of the number of shareholders within a private company affect growth strategy?
- How does the JOBS Act facilitate liquidity?